Sujay Kango's Net Worth
$3.01 Million
Who is Sujay Kango?
Sujay Kango has an estimated net worth of $3.01 Million. This is based on reported shares across multiple companies, which include INFINITY PHARMACEUTICALS, INC., MEI Pharma, Inc., and ACCELERON PHARMA INC.
SEC CIK
Sujay Kango's CIK is 0001336503
Past Insider Trading and Trends
2021 was Sujay Kango's most active year for acquiring shares with 7 total transactions. Sujay Kango's most active month to acquire stocks was the month of December. 2021 was Sujay Kango's most active year for disposing of shares, totalling 20 transactions. Sujay Kango's most active month to dispose stocks was the month of December. 2021 saw Sujay Kango paying a total of $1,015,250.00 for 109,639 shares, this is the most they've acquired in one year. In 2021 Sujay Kango cashed out on 166,483 shares for a total of $3,843,737.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.000001
Chief Commercial OfficerSujay Kango owns 599 units of Common Stock which is worth $0.00.acquired a total of 75,000 shares in INFINITY PHARMACEUTICALS, INC., Sujay also disposed a total of 75,000 shares of INFINITY PHARMACEUTICALS, INC. equalling to $95,870.68.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -99.21% | -75.00K |
$1.28 | -$95,870.68 | 599 |
Dec 12 - Dec 13
| |||
Form 4
| +12,520.87% | 75K |
—
|
—
| 75.6K |
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEI Pharma, Inc. (MEIP) Snapshot price: $3.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACCELERON PHARMA INC No price found
EVP, Chief Commercial OfficerSujay Kango used to own units in Common Stock but no longer holds any shares there. In the year 2021 Sujay Kango filed a total of 15 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -18.51K |
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
$107.81 | -$671,950.00 | 18.51K |
Scheduled
|
Sep 27
| ||
Form 4
|
—
|
0
|
$95.32 | -$547,100.00 | 18.51K |
Scheduled
|
Sep 21
| ||
Form 4
| -4.57% | -887.00 |
$130.87 | -$116,081.69 | 18.51K |
Feb 12
| |||
Form 4
|
—
|
0
|
$88.31 | -$477,008.76 | 19.4K |
Scheduled
|
Mar 2
| ||
Form 4
| +38.67% | 5.41K |
—
|
—
| 19.4K |
Jan 29
| |||
Form 4/A
| +250.82% | 10K |
$40.61 | $406,100.00 | 13.99K |
Scheduled
|
Jan 4
| ||
Form 4
| -74.02% | -11.36K |
$125.25 | -$1,422,447.50 | 3.99K |
Scheduled
|
Jan 4
| ||
Form 4
| -3.73% | -595.00 |
$94.10 | -$55,987.20 | 15.34K |
Scheduled
|
Feb 13
| ||
Form 4
| +66.55% | 6.37K |
—
|
—
| 15.94K |
Jan 22
| |||
Form 4
| -4.78% | -480.00 |
$51.37 | -$24,656.50 | 9.57K |
Scheduled
|
Jan 3
| ||
Form 4
| +67.50% | 4.05K |
—
|
—
| 10.05K |
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||